AbbVie Valuation
| ABBV Stock | 25.39 0.22 0.86% |
At this time, the firm appears to be overvalued. AbbVie Inc CDR shows a prevailing Real Value of USD21.9 per share. The current price of the firm is USD25.39. Our model approximates the value of AbbVie Inc CDR from analyzing the firm fundamentals such as return on equity of 0.56, and Profit Margin of 0.09 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 50.3378 | Enterprise Value 526.1 B | Enterprise Value Ebitda 20.5819 | Price Sales 7.9239 | Forward PE 14.4928 |
Overvalued
Today
Please note that AbbVie's price fluctuation is very steady at this time. Calculation of the real value of AbbVie Inc CDR is based on 3 months time horizon. Increasing AbbVie's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the AbbVie stock is determined by what a typical buyer is willing to pay for full or partial control of AbbVie Inc CDR. Since AbbVie is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AbbVie Stock. However, AbbVie's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 25.39 | Real 21.9 | Hype 25.39 | Naive 26.44 |
The real value of AbbVie Stock, also known as its intrinsic value, is the underlying worth of AbbVie Inc CDR Company, which is reflected in its stock price. It is based on AbbVie's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AbbVie's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of AbbVie Inc CDR helps investors to forecast how AbbVie stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AbbVie more accurately as focusing exclusively on AbbVie's fundamentals will not take into account other important factors: AbbVie Total Value Analysis
AbbVie Inc CDR is presently forecasted to have takeover price of 526.06 B with market capitalization of 440.04 B, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AbbVie fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
526.06 B | 440.04 B |
AbbVie Asset Utilization
One of the ways to look at asset utilization of AbbVie is to check how much profit was generated for every dollar of assets it reports. AbbVie Inc CDR utilizes its assets nearly 0.0772 percent, earning 0.0772 cents for each dollar of assets held by the firm. An expanding asset utilization signifies that the company is being more effective with each dollar of assets it shows. Put another way, asset utilization of AbbVie shows how effective it operates for each dollar spent on its assets.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AbbVie's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AbbVie and how it compares across the competition.
About AbbVie Valuation
The stock valuation mechanism determines AbbVie's current worth on a weekly basis. Our valuation model uses a comparative analysis of AbbVie. We calculate exposure to AbbVie's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AbbVie's related companies.Complementary Tools for AbbVie Stock analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |